Clinical Trials Directory

Trials / Completed

CompletedNCT00957541

Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device

Clinical Evaluation of the Physiological Diagnosis Function in the Paradym CRT Device

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
520 (actual)
Sponsor
ELA Medical, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the performance of a new sensor-based diagnostic feature, which has been implemented in a cardiac resynchronization therapy (CRT) device. This trial will study the effectiveness of the diagnostic feature to detect heart failure events in medically stable, ICD-indicated, congestive heart failure patients.

Detailed description

The purpose of this study is to evaluate the performance of a new sensor-based diagnostic feature, which has been implemented in a cardiac resynchronization therapy (CRT) device. This trial will study the effectiveness of the diagnostic feature to detect heart failure events in medically stable, ICD-indicated, congestive heart failure patients. The ability of the diagnostic feature to 'detect' and 'predict' heart failure events will be studied.

Conditions

Interventions

TypeNameDescription
DEVICEParadym CRT + Physiological Diagnosis (PhD)All subjects will undergo CRT therapy with the Physiological Diagnosis (PhD) feature enabled.

Timeline

Start date
2009-09-01
Primary completion
2011-04-01
Completion
2013-04-01
First posted
2009-08-12
Last updated
2014-05-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00957541. Inclusion in this directory is not an endorsement.

Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device (NCT00957541) · Clinical Trials Directory